Skip to content

Double blind placebo controlled trial of steroids in Bacterial Meningitis

Double blind placebo controlled trial of steroids in Bacterial Meningitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN42986828
Enrollment
Unknown
Registered
2005-07-22
Start date
1996-11-01
Completion date
Unknown
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial meningitis Nervous System Diseases Bacterial meningitis

Interventions

Double blind randomised controlled trial. The intervention will be dexamethasone.

Sponsors

University of Oxford (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The treating physician believes the diagnosis to be BM 2. History less than ten days (unless still Serebrospinal Fluid [CSF] evidence of bacteria) 3. CSF white cell count more than 50 with more than 50% neutrophils 4. CSF glucose less than 50% of blood glucose

Exclusion criteria

Exclusion criteria: 1. Chest X-Ray (CXR) shows evidence of possible Tuberculosis (TB) 2. History is longer than ten days 3. History of hypersensitivity to beta-lactam antibiotics 4. Known severe liver or renal impairment 5. Patients in whom the physician believes corticosteroids are contraindicated e.g. uncontrolled diabetes, gastro-intestinal bleeding etc. 6. Pre-existing severe neurological disability 7. Pregnancy within the first trimester

Design outcomes

Primary

MeasureTime frame
Mortality

Secondary

MeasureTime frame
No secondary outcome measures

Countries

Viet Nam

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 6, 2026